查看購物車
  • Simplified Chinese
  • English
  • Japanese
CHC 年鑑：2025
市場調查報告書
商品編碼
1630468

CHC 年鑑：2025

CHC YearBook 2025
出版日期: | 出版商: Nicholas Hall Group of Companies | 英文 300 Pages | 訂單完成後即時交付

價格
簡介目錄

它是消費者健康行銷人員的重要資源，可即時取得支援快速且準確決策所需的關鍵事實和數據。

CHC 年鑑：2025包含整個 CHC 市場的全通路數據，包括商店銷售、直銷 (MLM) 和網路/郵購銷售之間的劃分。一些章節反映了專用資料庫 "DB6" 的最新信息，並添加了透過這些管道銷售的詳細資訊。

CHC Almanac：2025被全球領先的 OTC、製藥和消費者保健公司、投資銀行和顧問公司使用。根據您的要求，該報告可透過各種數位授權（網站或全球）或單獨的印刷版取得。

本報告提供了重點數據和分析，並借鑒了我們在消費者健康領域基準測試方面的豐富知識和經驗。我們向您提供所有事實、所有數據。

世界評論

  • 它強調了關鍵發展和全球趨勢，並預測了 CHC 的未來前景。

區域評論

  • 它涵蓋八個主要地區並重點介紹主要市場、趨勢和發展。

主要市場

  • 它涵蓋15 個主要市場，按類別、主要行銷人員和品牌提供頂級數據。以及各國法規、交換環境、廣告和分銷的評論

類別評論

  • 涵蓋止痛藥、CCA、GI、VMS、Derma和Lifestyle CHC。

主要公司

  • 全球前20大CHC公司概況及全球前250強銷售額複合年增長率（2019-24）

併購

  • 涵蓋2019 年以來的主要併購、合資和合作趨勢，以及 CHC 產業的收購倍數

主要品牌

  • CHC 銷售額排名前250 名的品牌 - 以及前25 個品牌的簡要介紹

熱門話題

  • 影響消費者健康的當前主題分析


Rx 到 OTC 轉換

  • 主要市場轉換環境概述 - 以及主要處方藥到非處方藥轉換的概況


新產品開發與創新

  • CHC 類別的交付格式和目前 NPD 活動概述

全球零售趨勢

  • 全面概述快速變化的全球零售格局


所需參考表

  • 有關成分分類、公司所有權、品牌和營銷商、製造商協會以及CHC 詞彙表的信息

目錄

定義 CHC 市場

第1章 世界回顧

  • 世界概況
  • 競爭格局
  • 轉變
  • 品牌與創新
  • 零售業
  • 外表

第2章 區域回顧

  • 北美
  • 東亞和東南亞
  • 西歐
  • 中歐/東歐
  • 拉丁美洲
  • 日本
  • 印度次大陸
  • 澳大拉西亞

第3章 主要市場

  • 美國
  • 中國
  • 日本
  • 德國
  • 印度
  • 義大利
  • 俄羅斯
  • 法國
  • 巴西
  • 英國
  • 波蘭
  • 墨西哥
  • 加拿大
  • 澳洲
  • 印尼

第4章 分類審查

  • 止痛藥
  • 咳嗽、感冒、過敏
  • 胃腸藥
  • 維生素、礦物質和補充劑
  • 皮膚科
  • Lifestyle CHC

第5章 主要公司

  • Haleon
  • Kenvue
  • Bayer
  • Opella
  • P&G
  • Reckitt
  • China Resources 999
  • Taisho
  • Otsuka
  • Bausch Health
  • Abbott
  • Unilever
  • Nestle
  • Prestige Consumer Healthcare
  • Stada
  • Teva
  • Church &Dwight
  • Perrigo
  • Cooper Consumer Health
  • Alcon

第6章 併購

第7章 主要品牌

  • Vicks
  • Tylenol
  • Nature Made
  • Advil
  • Mucinex
  • Voltaren
  • Centrum
  • 999 Gan Mao Ling
  • Panadol
  • Halls
  • Nicorette
  • Dong-e E-Jiao
  • Nurofen
  • Zyrtec
  • Fupai E-Jiao
  • Claritin
  • Strepsils
  • Doliprane
  • Caltrate
  • Olly
  • Allegra
  • Nature's Bounty
  • Systane
  • Bayer Aspirin
  • Electrolit

第8章 熱門話題

  • GLP-1 的使用為 CHC 球員提供了許多機會
  • 建議和社區營造對女性健康越來越重要
  • 消化健康趨勢推動益生菌創新
  • 認知健康領域隨著創新浪潮而擴展

第9章 從處方藥轉為非處方藥

  • 概述
  • 西歐
  • 北美
  • 日本
  • 澳大拉西亞
  • 新興市場
  • 重大轉變
    • Allegra
    • Alli, Xenical
    • Astepro
    • Differin
    • Dymista
    • ellaOne
    • Flonase/Flixonase
    • Formigran
    • Hana, Lovima
    • Loxonin S
    • Maloff Protect
    • MiraLAX
    • Narcan
    • Nasacort
    • Nexium 24HR
    • Opill
    • Pataday
    • Plan B, NorLevo, Postinor, Levonelle
    • Prevacid 24HR
    • Silvasta、Maxon Active/Tadalafil MaxOn、Viagra Connect、Cialis
    • Voltaren
    • Xyzal
    • Zyrtec

第10章 新產品開發與創新

  • 止痛藥
  • 咳嗽、感冒、過敏
  • 胃腸藥
  • 維生素、礦物質和補充劑
  • 皮膚科
  • 生活方式CHC

第11章 全球零售趨勢

第12章 公司所有權

第13章：品牌與行銷人員

第14章 廠商會

第15章 詞彙表

簡介目錄

CHC FACTS & FIGURES IN FOCUS

A vital resource for Consumer Health marketers, offering instant access to the key facts & figures needed to support quick and accurate decision-making, including full year-end 2024 sales data from the only dedicated worldwide CHC sales database.

Expansive channel coverage

"CHC YearBook 2025" includes All channels data for the total CHC market, including splits for Store, Direct (MLM) and Internet & mail order sales. Selected chapters feature added detail of sales via these channels, reflecting the latest information from our dedicated 'DB6' database.

"CHC YearBook" is used by top OTC, pharma and consumer health companies, investment banks and consultants around the world. Depending on your requirements, the report is available in various digital licences (Site or Global) or as individual print copies.

With extensive knowledge and experience in benchmarking the world of consumer health, Nicholas Hall's "CHC YearBook 2025" provides a focused set of data and analysis. Find all the facts, all the figures, at your fingertips.

Global Review

  • Highlighting major developments and global trends, and forecasting the CHC outlook for the future

Regional Review

  • 8 major regions come under the spotlight, with the focus on key markets, trends and developments

Leading Markets

  • Coverage of the Top 15 markets includes topline data by category, leading marketers and brands - PLUS a country-by-country review of regulations, switch environment, advertising and distribution

Category Review

  • Global coverage of Analgesics, CCA, Gastrointestinals, VMS, Derma and Lifestyle CHC

Leading Companies

  • Profiles of the Top 20 CHC players across the world. Leading 250 CHC marketers by sales with CAGR 2019-24

Mergers & Acquisitions

  • All the major M&A activity, joint-ventures and alliances since 2019 - PLUS coverage of multiples paid for acquisitions in the CHC industry

Leading Brands

  • The leading 250 CHC brands by sales - PLUS concise profiles of the Top 25 brands

Hot Topics

  • Analysis of the latest hot-button issues affecting consumer health


Rx-to-OTC Switch

  • Overview of the switch environment in key markets - PLUS profiles of significant Rx-to-OTC switches


New Product Development & Innovation

  • Overview of latest activity in delivery formats and NPD across CHC categories

Global Retailing

  • Comprehensive overview of the fast-changing global retailing environment


Essential Reference Tables

  • Information on classification of ingredients, company ownership, brands & marketers and manufacturers' associations - PLUS a CHC glossary

Table of Contents

CHC Market Definition

1. Global Review

  • World Overview
  • Competitive Landscape
  • Switch
  • Brands & Innovation
  • Retailing
  • Outlook

2. Regional Review

  • North America
  • East & South East Asia
  • Western Europe
  • Central & Eastern Europe
  • Latin America
  • Japan
  • Indian Subcontinent
  • Australasia

3. Leading Markets

  • USA
  • China
  • Japan
  • Germany
  • India
  • Italy
  • Russia
  • France
  • Brazil
  • UK
  • Poland
  • Mexico
  • Canada
  • Australia
  • Indonesia

4. Category Review

  • Analgesics
  • Cough, cold & allergy
  • Gastrointestinals
  • Vitamins, minerals & supplements
  • Dermatologicals
  • Lifestyle CHC

5. Leading Companies

  • Haleon
  • Kenvue
  • Bayer
  • Opella
  • P&G
  • Reckitt
  • China Resources 999
  • Taisho
  • Otsuka
  • Bausch Health
  • Abbott
  • Unilever
  • Nestle
  • Prestige Consumer Healthcare
  • Stada
  • Teva
  • Church & Dwight
  • Perrigo
  • Cooper Consumer Health
  • Alcon

6. Mergers & Acquisitions

7. Leading Brands

  • Vicks
  • Tylenol
  • Nature Made
  • Advil
  • Mucinex
  • Voltaren
  • Centrum
  • 999 Gan Mao Ling
  • Panadol
  • Halls
  • Nicorette
  • Dong-e E-Jiao
  • Nurofen
  • Zyrtec
  • Fupai E-Jiao
  • Claritin
  • Strepsils
  • Doliprane
  • Caltrate
  • Olly
  • Allegra
  • Nature's Bounty
  • Systane
  • Bayer Aspirin
  • Electrolit

8. Hot Topics

  • GLP-1 usage offers numerous opportunities for CHC players
  • Advice and community-building increasingly key in women's health
  • Trend for health through digestion driving innovation in probiotics
  • Rush of innovation expands cognitive health segment

9. Rx-to-OTC Switch

  • Overview
  • Western Europe
  • North America
  • Japan
  • Australasia
  • Emerging markets
  • The Big Switches
    • Allegra
    • Alli, Xenical
    • Astepro
    • Differin
    • Dymista
    • ellaOne
    • Flonase / Flixonase
    • Formigran
    • Hana, Lovima
    • Loxonin S
    • Maloff Protect
    • MiraLAX
    • Narcan
    • Nasacort
    • Nexium 24HR
    • Opill
    • Pataday
    • Plan B, NorLevo, Postinor, Levonelle
    • Prevacid 24HR
    • Silvasta, MaxOn Active / Tadalafil MaxOn, Viagra Connect, Cialis
    • Voltaren
    • Xyzal
    • Zyrtec

10. New Product Development & Innovation

  • Analgesics
  • Cough, Cold & Allergy
  • Gastrointestinals
  • Vitamins, Minerals & Supplements
  • Dermatologicals
  • Lifestyle CHC

11. Global Retailing

12. Company Ownership

13. Brands & Marketers

14. Manufacturers' Associations

15. Glossary

Charts

  • Chart 1: Global CHC sales by region 2024
  • Chart 2: Global CHC sales by category 2024
  • Chart 3: Global CHC forecasts by region
  • Chart 4: Global CHC forecasts by category
  • Chart 5: North America CHC market by category 2024
  • Chart 6: North America leading CHC marketers & brands 2024
  • Chart 7: E&SE Asia CHC market by category 2024
  • Chart 8: E&SE Asia leading CHC marketers & brands 2024
  • Chart 9: Western Europe CHC market by category 2024
  • Chart 10: Western Europe leading CHC marketers & brands 2024
  • Chart 11: C&E Europe CHC market by category 2024
  • Chart 12: C&E Europe leading CHC marketers & brands 2024
  • Chart 13: Latin America CHC market by category 2024
  • Chart 14: Latin America leading CHC marketers & brands 2024
  • Chart 15: Japan CHC market by category 2024
  • Chart 16: Japan leading CHC marketers & brands 2024
  • Chart 17: Indian Subcontinent CHC market by category 2024
  • Chart 18: Indian Subcontinent leading CHC marketers & brands 2024
  • Chart 19: Australasia CHC market by category 2024
  • Chart 20: Australasia leading CHC marketers & brands 2024
  • Chart 21: Global leading 15 CHC markets 2024
  • Chart 22: USA CHC market by category 2024
  • Chart 23: USA leading CHC marketers & brands 2024
  • Chart 24: China CHC market by category 2024
  • Chart 25: China leading CHC marketers & brands 2024
  • Chart 26: Japan CHC market by category 2024
  • Chart 27: Japan leading CHC marketers & brands 2024
  • Chart 28: Germany CHC market by category 2024
  • Chart 29: Germany leading CHC marketers & brands 2024
  • Chart 30: India CHC market by category 2024
  • Chart 31: India leading CHC marketers & brands 2024
  • Chart 32: Italy CHC market by category 2024
  • Chart 33: Italy leading CHC marketers & brands 2024
  • Chart 34: Russia CHC market by category 2024
  • Chart 35: Russia leading CHC marketers & brands 2024
  • Chart 36: France CHC market by category 2024
  • Chart 37: France leading CHC marketers & brands 2024
  • Chart 38: Brazil CHC market by category 2024
  • Chart 39: Brazil leading CHC marketers & brands 2024
  • Chart 40: UK CHC market by category 2024
  • Chart 41: UK leading CHC marketers & brands 2024
  • Chart 42: Poland CHC market by category 2024
  • Chart 43: Poland leading CHC marketers & brands 2024
  • Chart 44: Mexico CHC market by category 2024
  • Chart 45: Mexico leading CHC marketers & brands 2024
  • Chart 46: Canada CHC market by category 2024
  • Chart 47: Canada leading CHC marketers & brands 2024
  • Chart 48: Australia CHC market by category 2024
  • Chart 49: Australia leading CHC marketers & brands 2024
  • Chart 50: Indonesia CHC market by category 2024
  • Chart 51: Indonesia leading CHC marketers & brands 2024
  • Chart 52: Global CHC analgesics category split 2024
  • Chart 53: Leading analgesic brands 2024
  • Chart 54: Global CHC CCA category split 2024
  • Chart 55: Leading CCA brands 2024
  • Chart 56: Global CHC GIs category split 2024
  • Chart 57: Leading GI brands 2024
  • Chart 58: Global CHC VMS category split 2024
  • Chart 59: Leading VMS brands 2024
  • Chart 60: Global CHC dermatologicals category split 2024
  • Chart 61: Leading dermatological brands 2024
  • Chart 62: Global lifestyle CHC category split 2024
  • Chart 63: Leading lifestyle CHC brands 2024
  • Chart 64: Top 250 CHC marketers 2024
  • Chart 65: CHC merger, acquisition, alliance & joint-venture activity 2020-2025
  • Chart 66: Multiples paid for CHC acquisitions 2020-2024
  • Chart 67: Leading CHC brands 2024
  • Chart 68: Legal status of ingredients in selected world markets
  • Chart 69: Legal status of ingredients in selected European markets (I)
  • Chart 70: Legal status of ingredients in selected European markets (II)
  • Chart 71: Big Switches global CHC sales 2024
  • Chart 72: Company Ownership Index
  • Chart 73: Brands & Marketers Index